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Dear Editors,
After observing an increased incidence of imprecise and 
sometimes erroneous use of nuclear chemistry, radiochem-
istry, and radiopharmacy related terms and nomenclature in 
scientific reports, an international working group of experts 
was assembled to address the issue. Upon extensive con-
sultation with peers within the field of radiochemistry and 
radiopharmaceutical sciences over a 3-year period and an 
open discussion, consensus was achieved during the Inter-
national Symposium on Radiopharmaceutical Sciences ear-
lier last year in an open forum. The resulting, harmonised 
nomenclature recommendations have now been published 
with following aims given therein1:
• Provide a reference source for nomenclature good prac-
tice in the radiopharmaceutical sciences.
• Clarify the use of terms and rules concerning exclusively 
radiopharmaceutical terminology, i.e. nuclear- and radio-
chemical terms, symbols, and expressions.
• Address gaps and inconsistencies in existing radiochem-
istry nomenclature rules.
• Provide source literature for further harmonisation 
beyond our immediate peer group (publishers, editors, 
IUPAC, pharmacopoeias, etc.).
To disseminate further the consensus recommendations, a 
summary (see below) has been prepared for ease of reference 
and for open dissemination across the field. We hope that 
your journal will consider incorporating these guidelines as 
part of your journals’ manuscript preparation instructions.
Yours sincerely,
Heinz H. Coenen and Antony D. Gee
International consensus nomenclature 
Guidelines: summary2
Measures of radioactivity
Unit of activity
“Radioactivity” is a physical phenomenon, defined as the 
property of certain nuclei to spontaneously fragment or rear-
range, resulting in the emission of radiation.
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“Activity” is the quantitative measure of radioactivity: 
the number of nuclear decays, occurring in a given quantity 
of material over a certain time interval, divided by that time 
interval.
“Becquerel” (Bq) is the agreed SI derived unit for the 
quantity of activity.
Pre-SI units (e.g. imperial units) (e.g. mCi, Ci) can also 
be used, but must be placed in parentheses after the stated 
SI units.
N.B.:The correct terms “radioactive” and “non-radio-
active” must not be replaced by the lab-jargon “hot” and 
“cold”, respectively, in public or official documents.
Molar activity (Am) and specific activity (As)
Molar activity is the measured activity per mole of com-
pound; measured in Bq/mol (GBq/µmol).
Specific activity is the measured activity per gram of 
compound; measured in Bq/g (GBq/µg).
Due to radioactive decay, the instant of time of measure-
ment must be stated; for example: “The molar activity was 
50 GBq/µmol 2 h after the end of synthesis”.
Apparent molar activity and apparent specific activity
The terms “apparent molar activity” and “apparent spe-
cific activity” take into account the amounts of the labelled 
and non-radiolabelled impurities present (using moles, or 
weight, respectively).
Effective molar activity and effective specific activity
The terms “effective molar activity” and “effective specific 
activity” address the chemically, biologically, or pharmaco-
logically ‘active’ fraction of radioactive and non-radioactive 
materials in a sample, competing with the labelled product 
in its chemical or biological reactions.
In this case, the “effectivity” must be determined by an 
additional analytical process; e.g., receptor or enzyme bind-
ing assay, side-product analysis, etc.
Other terms like “pseudo-specific activity” etc. must not 
be used.
‘No‑carrier added’, ‘carrier added’, and ‘carrier‑free’
The non-quantitative terms, “no-carrier-added” (n.c.a.) and 
“carrier-added” (c.a.), can be used as a practical, qualitative 
indication of specific or molar activity.
The term “carrier-free” (c.f.) can only be used in the rare 
case, where the theoretical maximum specific or molar activ-
ity is unambiguously proven.
Measures involving determination of amounts of mate-
rial (e.g., molar activity or radiochemical purity) should 
be accompanied by a clear description of the method of 
detection.
Radionuclide and radioisotope descriptors
The enrichment of a chemical compound with an isotope 
(stable or radioactive) of one or more of the elements, of 
which it is constituted, is indicated by the symbol of the ele-
ment (E) together with its mass number (A) (as a superscript 
in front) within square brackets,  [AE], immediately preced-
ing the compound’s name or chemical formula.
Example:  [2H,14C]benzene, or  [2H,14C]C6H6, represent 
the compound benzene, enriched or labelled, with stable 
deuterium and radioactive carbon-14, respectively.
For rules designating labelling positions (e.g., l-[methyl-
11C]methionine or l-[carboxyl-11C]methionine), see : http://
goldb ook.iupac .org/pages /about .html.
These rules apply equally to organic, inorganic, and orga-
nometallic compounds and complexes: e.g.  [223Ra]RaCl2, 
 [99mTc]NaTcO4,  [99mTc]Tc-MDP,  [68Ga]Ga-DOTA-TATE, 
etc.
As square brackets are also used to denote metal com-
plexes, care should be taken to avoid confusion with radio-
nuclide descriptors, e.g.  [99mTc][Tc(CO)3(OH2)3]+,  [111In]
[In(DTPA)]2−, etc.
N.B. The symbol for isotopic enrichment  [AE] should be 
treated like a syllable, and thus only be hyphenated at the 
end of a line of text.
Conversely, do not use nuclide symbols in square brackets 
in combination with nouns and verbs.
Examples of the use of square brackets and hyphens: 
Correct Incorrect
l-[13N]alanine, (S)-[13N]alanine [13N] l-alanine, (S)-13N-alanine, 
L-[13N]-alanine
[18F]fluorobenzene [18F]benzene (no fluorine atom in 
benzene)
[99mTc]TcDTPA2− [99mTc]DTPA2−, 99mTc-DTPA2 (no 
Tc in chelator)
11C-compound, 125I-substitution, 
18F-derivative, 68Ga-conjugate 
77Br-reagent
[11C]compound, 
 [125I]-substitution, 
 [18F]-derivative,  [68Ga]conjugate 
(no chemical compound names)
11C-labelling, 64Cu-labelling, 
18F-fluorination (with hyphen!)
[11C]labelling,  [64Cu]-labelling, 
 [18F]-(radio)-fluorination (no 
chemical compound names)
The terms ‘(radio)isotope’ and ‘(radio)nuclide’ are often 
used incorrectly in texts, inferring “isotope” means “radioac-
tive nuclide” or even “labelled compound.”
• ‘Nuclide’ indicates an atom, characterised by its num-
bers of protons (identifying its elemental nature) and of 
nucleons (indicating its mass).
238 Annals of Nuclear Medicine (2018) 32:236–238
1 3
• ‘Isotopes’ are nuclides of the same element (same pro-
ton number), but having different numbers of neutrons 
(hence different atomic mass).
• Isotopic nuclides of different energy state are called iso-
meric nuclides, isomeric isotopes, or ‘isomers’, such as 
technetium-99g and -99m.
N.B. All (radio)isotopes are (radio)nuclides, while the 
reverse is not true!
Radiochemical yield (RCY)
The “radiochemical yield” is the amount of activity in the 
product expressed as the percentage (%) of related starting 
activity utilized in the considered process (e.g. synthesis, 
separation, etc.). The quantity of both must relate to the 
same radionuclide and be decay corrected to the same point 
in time before the calculation is made.
(reported measures of RCY should indicate, whether a 
product was isolated or not).
Colloquial expressions for “radio-yield” found in lit-
erature, e.g. ‘radiochemical conversion’, ‘analytical radio-
chemical yield’, and ‘radio-HPLC yield’, must not be used 
as a surrogate for ‘radiochemical yield’ or ‘radiochemical 
purity’, respectively.
The following text may serve as examples for good prac-
tice, when describing a radiochemical yield:
‘The radiochemical yield was 67% (based on HPLC anal-
ysis of the crude product).”
‘The radiochemical yield* of “Y” was 67%”, with the 
following as a footnote:
• *“determined by radio-HPLC analysis of the crude prod-
uct”, or
• *“non-isolated, estimated by radio-HPLC”,
or, in the general experimental section: “All radiochemi-
cal yields were determined by HPLC of the crude product, 
unless stated otherwise”,
or alternatively use: ‘The radiochemical purity of the 
crude product was 67%”,
or: “The radiochemical yield of “Y” determined from an 
aliquot of the reaction solution amounted to 67%”,
or: “The radiochemical yield of crude “Y” was 67% based 
on the amount of activity eluted from the HPLC column”.
Expressions such as ‘conversion’ or ‘incorporation’, how-
ever, may be used in a semantic sense and even be indispen-
sable in context of mechanistic discussions. For example, 
“The ‘conversion’ (or ‘incorporation’) proceeded with a 50% 
yield. Here, it is clear from the context that the radiochemi-
cal yield of the conversion is intended.
Activity yield
The “activity yield” is the amount of radioactive product 
expressed in Bq (MBq, GBq), which is obtained from a start-
ing amount of activity (e.g. produced at a cyclotron) and is 
not corrected for decay.
This term is useful, or necessary to indicate the efficiency 
of a labelling procedure. The activity yield is, of course, 
dependent on the effectiveness and duration of all technical 
manipulations used, in addition to the yield of the labelling 
reaction.
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